Pulse Biosciences (PLSE) Debt Ratio (2021 - 2023)

Name: Pulse Biosciences (PLSE) Debt Ratio (2021 - 2023) | Business Quant
Creator: Business Quant

Pulse Biosciences' quarterly Debt Ratio came in at 0.93 in Q1 2023, up 10.9% quarter-over-quarter from 0.83 in Q4 2022.

Pulse Biosciences has reported Debt Ratio for 3 years, with the latest figure at 0.93 in Q1 2023.

For the quarter ending Q1 2023, Debt Ratio changed N/A year-over-year to 0.93; the trailing twelve-month figure through Mar 2023 stood at 0.93 (changed N/A YoY), and the FY2022 full-year result was 0.83, changed N/A from the prior year.
Debt Ratio for Q1 2023 stood at 0.93, up from 0.83 in the prior quarter.
The five-year high for Debt Ratio was 0.93 in Q1 2023, with the low at 0.51 in Q1 2021.
Average Debt Ratio over 3 years is 0.75, with a median of 0.79 recorded in 2022.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Intuitive Surgical	156.17 Bn	151.78 Bn	1.83 Bn	-
2	Becton Dickinson	41.51 Bn	40.49 Bn	2.15 Bn	0.34
3	Resmed	30.43 Bn	28.77 Bn	890.98 Mn	0.03
4	West Pharmaceutical Services	22.78 Bn	22.26 Bn	296.40 Mn	0.05
5	Solventum	13.39 Bn	13.39 Bn	1.10 Bn	0.36
6	Cooper Companies	12.33 Bn	12.20 Bn	695.20 Mn	0.20
7	Align Technology	11.65 Bn	10.59 Bn	736.59 Mn	-
8	Baxter International	9.81 Bn	7.77 Bn	891.00 Mn	0.48
9	Aptargroup	7.39 Bn	7.19 Bn	351.91 Mn	0.23
10	Pulse Biosciences	1.72 Bn	1.72 Bn	-	-

Download Data 🔒